Japanese pharmaceutical company Astellas decided to reduce the production of the antibiotic Vilprafen in Russia. This was reported by RBC.
The pharmaceutical company did not explain the reason for this decision. The publication writes that hospital supplies of the drug will take about six months.
The international name of this antibiotic is josamycin. According to RBC, in the second half of December the supply of these drugs in Russia was almost exhausted. The Russian Ministry of Health has recommended replacing it with azithromycin, but patients may be resistant to it.
As of December 21, vilprafen solutab was available in only one of the 2.5 thousand pharmacies connected to the Megapteka service. And vilprafen was not available at all. Tambov, St. There were no medicines containing josamycin in any pharmacy in St. Petersburg or Perm.
Before that, scientists from the Federal Scientific Center for Physics and Chemistry Yu.M. Lopukhin and MIPT developed A new compound with antiviral activity that blocks coronavirus replication.
doctors before to create Medicines that slow the progression of dementia.